Social Capital Suvretta Holdings Corp. I (DNAA) News
Filter DNAA News Items
DNAA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest DNAA News From Around the Web
Below are the latest news stories about SOCIAL CAPITAL SUVRETTA HOLDINGS CORP I that investors may wish to consider to help them evaluate DNAA as an investment opportunity.
Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with RobloxBOSTON & SANTA MONICA, Calif., May 26, 2022--Akili Interactive ("Akili"), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, and Roblox (NYSE: RBLX), a global platform bringing millions of people together through shared experiences, today announced a collaboration that connects patients' medical treatments to their favorite virtual worlds. |
Akili to Present at Chardan’s Prescription Digital Therapeutics Half-Day SummitBOSTON, April 04, 2022--Akili Interactive ("Akili" or the "Company"), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today announced that management will present at Chardan’s Prescription Digital Therapeutics Half-Day Summit on Monday, April 11, 2022 at 2:00 p.m. E.T. |
Game Industry Veteran Behind Bejeweled, Plants vs. Zombies Joins Akili as Chief Product OfficerBOSTON, March 17, 2022--Akili Appoints Game Industry Veteran Jon David as Chief Product Officer |
Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital TherapeuticsBOSTON, March 10, 2022--Akili to Speak at SXSW 2022 on Building a New Class of Disease-Modifying Digital Therapeutics |
Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022BOSTON, March 08, 2022--Akili has been named to Fast Company's Annual list of the World's 50 Most Innovative Companies |
Akili to Present at Cowen’s 42nd Annual Health Care ConferenceBOSTON, March 07, 2022--Akili Management to Present at Cowen's 42nd Annual Health Care Conference |
Akili to Speak on Integrating Digital Therapeutics Into Mainstream Healthcare at DTx West 2022BOSTON, February 18, 2022--Akili Chief Financial Officer and Vice President of Marketing will speak at leading digital therapeutics conference, DTx West |
PLOS ONE Publishes Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional FunctioningBOSTON, February 17, 2022--New data published from a study of Akili's EndeavorRx shows the how the digital therapeutic effects brain activity of a child with ADHD |
PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. IBOSTON, February 15, 2022--PureTech Founded Entity Akili Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with SCS |
Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. IBOSTON & PALO ALTO, Calif., February 14, 2022--Akili Announces Filing of S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I |